Indie Asset Partners, LLC Abbott Laboratories Transaction History

Indie Asset Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $190,462 - $230,208	-1,866 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $1,710 - $2,085	15 Added 0.81%	1,866 $221,000
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $3,465 - $4,243	-30 Reduced 1.59%	1,851 $261,000
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $3,499 - $3,871	30 Added 1.62%	1,881 $222,000
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $47,182 - $55,540	-446 Reduced 19.42%	1,851 $215,000
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $46,910 - $55,267	-431 Reduced 15.8%	2,297 $275,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $25,620 - $27,918	-244 Reduced 8.21%	2,728 $299,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $7,331 - $8,903	80 Added 2.77%	2,972 $323,000
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $221,440 - $283,416	2,892 New	2,892 $289,000
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $157,678 - $230,568	-2,510 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $197,060 - $219,374	2,510 New	2,510 $218,000

3,136

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indie Asset Partners, LLC with notifications on news.